China
Africa
Explore chapters and articles related to this topic
Assessment of Co-occurring Disorders, Levels of Care, and ASAM Requirements
Published in Tricia L. Chandler, Fredrick Dombrowski, Tara G. Matthews, Co-occurring Mental Illness and Substance Use Disorders, 2022
Elizabeth Reyes-Fournier, Tara G. Matthews, Tom Alexander
Young Mania Rating Scale: This scale is a clinical interview that takes less than 30 minutes to complete. It is used to measure the severity of mania and done primarily in hospital settings. It is not a screening tool and must be done by a trained clinician (Young et al., 1978).
Mood disorders
Published in Ben Green, Problem-based Psychiatry, 2018
Can moods be measured? Look out scales that propose to measure depression and mania such as the Beck Depression Inventory (BDI-II), Young Mania Rating Scale (YMRS) and the Mood Swings Questionnaire (MSQ). ➣ Try to find out how they are used and also how statistically reliable and valid they are.➣ How are such scales researched to see if they actually measure what they are supposed to measure?
Major Mood Disorders
Published in Dr. Ather Muneer, Mood Disorders, 2018
Hypomania is an under-recognized mood state but is, nonetheless, common. Patients do not always recall or read their mood accurately nor judge its consequences, and sometimes enjoy the mood state and view it as desirable. However, hypomania often heralds a manic or depressive episode, with ensuing severe consequences. Although patients typically struggle with depression, families and close associates often complain about the problematic outcomes of hypomanic episodes. Thus, the clinician must be on the lookout for hypomanic symptoms and should not let subtle changes in mood go unrecognized. In the clinical setting both history and mental state examination are helpful in this regard. However, a psychometric scale with good specificity and sensitivity can be invaluable and provides a measure of objectivity to the diagnostic process. In day-to-day practice, an instrument with such attributes is the Hypomania Checklist 32 (HCL-32), which is employed for the screening of hypomanic symptoms in patients with major depression.33 Easily administered, HCL-32 is helpful in diagnosing bipolarity in MDD subjects who experience subclinical symptoms and have never experienced full-fledged manic episodes. There is a caveat, all elements of assessment such as longitudinal course, family history and treatment response must be taken into account to correctly diagnose a depressed patient with bipolar spectrum disorders. Once a diagnosis of hypomania is made, other scales such as the Young Mania Rating Scale can be used to assess the severity of mood elevation.
Inflammatory and metabolic markers in patients with mood disorders
Published in The World Journal of Biological Psychiatry, 2021
Federico Mucci, Donatella Marazziti, Alessandra Della Vecchia, Stefano Baroni, Gabriele Massimetti, Paolo Morana, Paola Mangiapane, Florinda Morana, Barbara Carpita, Benedetto Morana, Liliana Dell’Osso
Ninety-seven BD inpatients were enrolled for the present study. All were recruited by reviewing the hospital charts of those admitted for the first time at the ‘Casa di Cura Morana’, Sicily (Italy), that is the largest public and, at a smaller extent private, neuropsychiatric hospital of northern Sicily within a larger collaboration established with the ‘Dipartimento di Medicina Clinica e Sperimentale’, Section of Psychiatry, University of Pisa. Diagnoses were carried out according to DSM-IV criteria, by means of the Mini International Neuropsychiatric Interview (Sheehan et al. 1998). The severity of symptoms, as recorded in the medical charts, were assessed by a battery of rating scales, specifically the Hamilton Rating Scale for Depression (HRSD) (Hamilton 1960), the Young Mania Rating Scale (YMRS) (Young RC et al. 1978), and the Clinical Global Impression-severity (CGI-s) (Guy 1976).
Resolvin D1 as a novel anti-inflammatory marker in manic, depressive and euthymic states of bipolar disorder
Published in Nordic Journal of Psychiatry, 2020
Burcu Kok Kendirlioglu, Pelin Unalan Ozpercin, Ozge Yuksel Oksuz, Sule Sozen, Refik Cihnioglu, Tevfik Kalelioglu, Mehmet Cem Ilnem, Nesrin Karamustafalioglu
Severity of mania was evaluated with the help of Young Mania Rating Scale (YMRS). Bipolar depression was assessed with the 17-item Hamilton Depression Rating Scale (HAM-D); a severity score of 20 or greater was required for inclusion. Euthymic state was defined as YMRS ≤7 and HAM-D score ≤7 for at least 8 weeks. Clinical diagnoses were established by a consensus of two senior psychiatrists following a psychiatric interview according to DSM-5. The healthy control group was selected from the individuals who had to come to the outpatient clinic for obligatory psychiatric examination prior to employment and adoption applications. Forty-one healthy volunteers without a psychiatric condition or a first-degree relative with a psychiatric diagnosis, matched for age, gender, and smoking status were recruited in the study. All groups were included of male individuals between 18 and 65 years of age. Individuals with mental retardation, dementia, any psychiatric disorder secondary to a medical condition, alcohol or substance use disorder, any medical condition affecting CNS; a personal history of atypical headaches, head trauma, chronic lung disease, renal disease, chronic hepatitis, thyroid disease, active cancer, cerebrovascular disease, epilepsy; acute infection or allergy, using medication including omega-3, asprin or any other drug with anti-inflammatory activity were excluded from this study. Each participant of this study provided informed and written consent.
Visual impairments in type 1 bipolar disorder
Published in The World Journal of Biological Psychiatry, 2019
Thiago P. Fernandes, Steven M. Silverstein, Natalia L. Almeida, Natanael A. Santos
Seventeen healthy controls (HCs) (M = 33.5 years; SD = 6.2 years) and 17 patients with type 1 BPD (M = 35.1 years; SD = 5.2 years), 21–45 years old, participated in the study. The BPD group consisted of outpatients who were recruited from the Psychosocial Care Centre and from private clinics in Paraiba and Coimbra, respectively. The patients met the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (American Psychiatric Association 2013) (DSM-5) criteria for type 1 BPD. We also evaluated the patients using the Young Mania Rating Scale (YMRS) (Young et al. 1978). All of the patients met the criteria for acute mania (YMRS scores > 15) (Lukasiewicz et al. 2013) and were free of systemic conditions. The BPD patients were taking lithium (n = 16) or olanzapine (n = 2) for more than 5 years at the time of the study. The lithium mean dose was 950 mg/day (SD = 495 mg/day) and the olanzapine mean dose was 10 mg/day. The outpatients were taking only these medications with similar dosages.